| Mepha Pharma AG - Lacosamid-Mepha 50 mg, Filmtabletten | | 67630 | | 01 | | Lacosamid-Mepha 50 mg | | Filmtabletten | | N03AX18 | | Lacosamide | | 26.06.2021 | | |
| | Composition | | Filmtablette: lacosamidum 50 mg, cellulosum microcristallinum, hydroxypropylcellulosum, silica colloidalis anhydrica, crospovidonum, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum, talcum, E 171, E 172 (rubrum), E 172 (nigrum), E 172 (flavum), pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. | informations additionels |
|---|
| Lacosamidum | 50 mg | Filmtablette |
| | BAG: Principe actif | Concentr. |
|---|
| Lacosamidum | 50 mg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| (Flavum) | | | | (Nigrum) | | | | (Rubrum) | | | | Cellulosum Microcristallinum | | | | Crospovidonum | | | | E 171 | | color. | | E 172 | | color. | | Hydroxypropylcellulosum | | | | Macrogol | | | | Magnesii Stearas | | | | Poly(Alcohol Vinylicus) | | Überzug | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 14 | 5.41 | 15.10 | B | LS | Oui |
|
|
